Enzyme ImmunoAssay (EIA) is a technique to detect and quantify antigens (proteins, hormones…) or antibodies in samples. It relies on the ability of an antibody to bind a specific antigen. Either the antibody or the antigen is labelled with an enzyme wh...
MoreThis product can not be purchased online. Please contact us
Size | 96 wells |
Shipping | dry ice |
Specificity | |
Application Media | Plasma |
Tracer | AcetylCholinesterase AChE |
Detection Limit | 10 pg/mL |
Standard Curve Range | 16-2000 pg/mL |
Custom Code | 3822000000 |
UNSPSC code | 41116104 |
PRODUCT EXPLANATION: ACETYLCHOLINESTERASE MARKER IN ENZYME-IMMUNOASSAYS
Grassi J., Pradelles P. Compounds labelled by the acetylcholinesterase of Electrophorus Electricus. Its preparation process and its use as a tracer or marquer in enzymo-immunological determinations. United States patent, N° 1,047,330. September 10, 1991
Grassi J., Pradelles P. The use of Acetylcholinesterase as a Universal marker in Enzyme-Immunoassays. Proceedings of the Third International Meeting on Cholinesterases, American Chemical Society (1991)
Pradelles P., Grassi J., Maclouf J. Enzyme Immunoassays of Eicosanoids Using Acetylcholinesterase. Methods in Enzymology (1990), vol. 187, 24-34
PRODUCT EXPLANATION: ANGIOTENSIN I
Speth RC, Giese MJ , Update on the Renin-Angiotensin System. J Pharmacol Clin Toxicol 1(1): 1004 (2013)
Ghazi L, Drawz P., Advances in understanding the renin-angiotensin-aldosterone system (RAAS) in blood pressure control and recent pivotal trials of RAAS blockade in heart failure and diabetic nephropathy. F1000Res. 2017 Mar 21;6. pii: F1000 Faculty Rev-297
Vian J, Pereira C, Chavarria V et al, The renin-angiotensin system: a possible new target for depression. BMC Med. 2017 Aug 1;15(1):144
Pacurari, Kafoury R., Tchounwou P.B. and Ndebele K., The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling.International Journal of Inflammation, Volume 2014, Article ID 689360
Paulis L, Unger T. Novel therapeutic targets for hypertension. Nat Rev Cardiol. 2010 Aug;7(8):431-41
PRODUCT EXPLANATION: KIT DEVELOPMENT
Valentin MA, Ma S, Zhao A, Legay F, Avrameas A. Validation of immunoassay for protein biomarkers: Bioanalytical study plan implementation to support pre-clinical and clinical studies. J Pharm Biomed Anal. (2011) 55(5): 869-877
European Medicines Agency. Guideline on bioanalytical method validation, 21 July 2011